Last reviewed · How we verify

A Food Effect Study of 60mg ER Torsemide

NCT03215875 PHASE1 COMPLETED

This study will evaluate the effects of a high-fat meal (food effect) on the bioavailability and pharmacokinetics of 60mg ER Torsemide tablet after single dose oral administration in healthy volunteers. The study will be conducted as a two-sequence to period crossover study to compare 60mg ER Torsemide ER bioavailability under fed and fasting conditions. 60mg ER torsemide is a new strength and dosage form.

Details

Lead sponsorSarfez Pharmaceuticals, Inc.
PhasePHASE1
StatusCOMPLETED
Enrolment28
Start dateTue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionSat Mar 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

India